Clinical implications of poststroke hypothalamo-pituitary adrenal axis dysfunction: A critical literature review

Journal of Stroke and Cerebrovascular Diseases

Volumn 6, Issue 6, 1997, Pages 377-388

  Mitchell, Alexander J ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

Cerebrovascular disorders; Cognitive impairment; Depression; Glucose; HPA axis; Prognosis

Indexed keywords

EID: 0001394628     PISSN: 10523057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1052-3057(97)80038-9     Document Type: Review

References (114)

1. Selye H.A. A syndrome produced by diverse nocious agents. Nature 138 (1936) 32-34
2. Romero L.M., and Sapolsky R.M. Patterns of ACTH secretatagog secretion in response to psychological stimuli. J Neuroendocrinol 8 (1996) 243-256
3. Jacobson L., and Sapolsky R. The role of the hippocampus in feedback regulation of the hypothalamo-pituitary-adrenal axis. Endocrinol Rev 12 (1991) 118-133
4. Sapolsky R.M. Glucocorticoid neurotoxicity. In: Sapolsky R.M. (Ed). Stress, the aging brain, and the mechanisms of neuron death (1992), MIT press, London 97-115
5. DeKosky S., Scheff S., and Cotman C. Elevated corticosterone levels: a mechanism for impaired, sprouting in the aged hippocampus. Neuroendocrinol 38 (1984) 33
6. Sapolsky R.M. The physiological relevance of glucocorticoid endangerment of the hippocampus. In: De Kloet E.R., Azmitia E.C., and Landfield P.W. (Eds). Brain corticosteroid receptors studies on the mechanism. Ann NY Acad Sci 746 (1994) 294-307
7. Ch. McEwen B.S. Re-examination of the glucocorticoid hypothesis of stress and aging. In: Swaab D.F., Hofman M.A., Mirmiran M., Ravid R., and Van Leeuwen F.W. (Eds). Progress in brain research Vol. 93 (1992), Elsevier, New York 365-383
8. Reincke M., Lehman R., Karl M., Magiakou A., Chrousos G.P., and Allolio B. Severe illness neuroendocrinology. In: Chrousos G.P., McCarty R., Pacak K., Cizza G., Sternberg E., Gold P.W., et al. (Eds). Stress basic mechanisms and clinical implications. Ann NY Acad Sci (1995) 556-569
9. Chioléro R., and Berger M. Endocrine response to brain injury. New Horizons 2 (1994) 432-442
10. Pulsinelli W., and Duffy T. Regional energy balance in rat brain after transient forebrain ischaemia. J Neurochem 40 (1983) 1500-1503
11. Robinson R.G. Differential behavioural effects of right versus left hemispheric infarction: evidence for cerebral lateralization in the rat. Science 205 (1979) 707-710
12. Feibel J., Kelly M., Lee L., and Woolf P. Loss of adrenocortical suppression after brain injury: role of increased intracranial, pressure and brain stem function. J Clin Endocrinol Metabol 57 (1983) 1245-1250
13. Miller A.H., Spencer R.L., McEwen B.S., and Stein M. Depression, adrenal steroids and the immune system. Annals of Medicine 25 (1993) 481-487
14. Oka M. Effect, of cerebral vascular accident on the level of 17-hydroxycorticosteroids in plasma. Acta Med Scand 156 (1956) 221-226
15. Fassbender K., Schmidt R., Mößner R., Daffertshofer M., and Hennerici M. Pattern of activation of the hypothalamic-pituitary-adrenal axis, in acute stroke. Relation to acute confusional state, extent of brain damage, and clinical outcome. Stroke 25 (1994) 1105-1108
16. Olsson T., Marklund N., Gustafson Y., and Nasman B. Abnormalities, at different levels of the hypothalamic-pituitary-adrenocortical axis early after stroke. Stroke 23 (1992) 1573-1576
17. Mather H.M., Ang V., and Jenkins J.S. Vasopressin in plasma and CSF of patients with subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 44 (1981) 216-219
18. Joynt R.J., Feibel J.H., and Sladek C.M. Antidiuretic hormone levels in stroke patients. Ann Neurol 9 (1981) 182-184
19. Murros K., Fogelholm R., Kettunen S., and Vuorela A.-L. Serum cortisol and outcome of ischemic brain infarction. J Neurol Sci 116 (1993) 12-17
20. Astrom M., Olsson T., and Asplund K. Different linkage of depression to hypercortisolism early versus late after stroke. A three year, longitudinal study. Stroke 24 (1993) 52-57
21. Neil-Dwyer G., Cruickshank J., Stott A., and Brice J. The urinary catecholamine and plasma cortisol levels in patients with subarachnoid haemorrhage. J Neurol Sci 22 (1974) 375-382
22. [Polish]. Marczak-Dzwonnik T. Effect of glucose load on blood cortisol levels in patients with stroke in the earliest period of the illness. Neurologia i Neurochirurgia Polska 21 (1987) 106-111
23. Zhao Y., Liu Z.-M., and Zhai C.-H. The change of peripheral leukocytic glucocorticoid receptor in patients with ischaemic and haemorrhagic stroke. Chinese J Int Med 28 (1989) 479-481
24. Zhao Y., Liu Z.-M., and Zhai C.-H. The change of peripheral leukocytic glucocorticoid receptor in patients with ischaemic and haemorrhagic stroke. Chinese J Int Med 28 (1989) 510
25. Elwan O., Abdallah M., Issa I., Taher Y., and El-Tamawy M. Hormonal changes in cerebral, infarction in the young and elderly. J Neurol Sci 98 (1990) 235-243
26. Famuyiwa O.O., Akanji A.O., Olutade B.O., and Ezenwaka C.E. Pattern of adrenocortical response to the stress of severe illness in Nigerians. Afr J Med 21 (1992) 67-72
27. Matchar D.B., Divine G.W., Heyman A., and Feussner J.R. The influence of hyperglycemia on outcome of cerebral infarction. Ann Int Med 117 (1992) 449-456
28. Dávalos A., Fernandez-Real J.M., Ricart W., Soler S., Molins A., Planas E., et al. Iron-related damage in acute ischaemic stroke. Stroke 25 (1994) 1543-1546
29. Dávalos A., Ricart W., Gonzalez-Huiz F., Soler S., Marrugat J., Molins A., et al. Effect of malnutrition after acute stroke on clinical outcome. Stroke 27 (1996) 1028-1032
30. American Psychiatric Association Committee on Nomenclature and Statistics Diagnostic and statistical manual of mental disorders. ed 3 (1987), American Psychiatric Association, Washington DC
31. (abstract 128), Umeå. Gustafson L. Organic Brain Syndrome Scale (OBS-scale). A new rating scale for evaluation of confusional, states and other organic brain syndromes. Second International Congress on Psychogeriatric Medicine (1985)
32. Hasegawa K., Inoue K., and Moriya K. An investigation of dementia rating scale for the elderly. Clin Psychiatry 16 (1974) 965-969
33. Charlton B.G., and Ferrier I.N. Hypothalamo-pituitary-adrenal axis abnormalities in depression: a review and a model. Psychol Med 19 (1989) 331-336
34. Olsson T. Urinary free cortisol excretion shortly after ischaemic stroke. J Int Med 228 (1990) 177-181
35. Culebras A., and Miller M. Dissociated patterns of nocturnal prolactin, cortisol and growth hormone secretion after stroke. Neurology 34 (1984) 631-636
36. Franceschini R., Gandolfo C., Cataldi A., Del Sette M., Cianciosi P., Finocchi C., et al. Twenty-four-hour β-endorphin secretory pattern in stroke patients. Stroke 25 (1994) 2142-2145
37. Suemaru S., Suemaru K., Hashimoto K., Ogasa T., Hirasawa R., Makino S., et al. Cerebrospinal fluid corticotropin-releasing hormone and ACTH and peripherally circulating choline-containing phospholipid in senile dementia. Life Sci 53 (1993) 697-706
38. Ch. Holsboer F., Spengler D., and Heuser I. The role of corticotropin releasing hormone in the pathologenesis of Cushing's disease, anorexia nervosa, alcoholism, affective disorders and dementia. In: Swaab D.F., Hofman M.A., Miriran M., Ravid R., and Van Leeuwen F.W. (Eds). Progress in brain research Vol. 93 (1992), Elsevier Science, New York 385-417
39. Wong M.-L., Loddick S.A., Bongiomo P.B., Gold P.W., Rothwell N.J., and Licinio J. Focal cerebral ischemia induces CRH mRNA in rat cerebral cortex and amygdala. Neuroreport 6 (1995) 1785-1788
40. Haba K., Ogawa N., Asanuma M., Hirata H., Sora Y.H., and Mori A. Changes of neuropeptides and their receptors in experimental stroke gerbil brains. J Neurol Sci 108 (1992) 88-92
41. Lipsey J.R., Robinson R.G., Pealson G.D., Rao K., and Price T.R. The dexamethasone suppression test and mood following stroke. Am J Psychiatry 142 (1985) 318-323
42. Reding M., Orto L., Willensky P., Fortuna I., Day N., Steiner S.F., et al. The dexamethasone suppression test in stroke but not a predictor of rehabilitation outcome. Arch Neurol 42 (1985) 209-212
43. Tracey F., Crawford V.L.S., Lawson J.T., Buchanan K.D., and Stout R.W. Hyperglycaemia and mortality from acute stroke. QJ Med 86 (1993) 439-446
44. Gustafson Y., Ollson T., Asplund K., and Hagg E. Acute confusional state (delirium) soon after stroke is associated with hypercortisolism. Cerebrovasc Dis 3 (1993) 33-38
45. Feibel J.H., Hardy P.M., Campbell R.G., Goldstein M.N., and Joynt R.J. Prognostic value of the stress response following stroke. JAMA 238 (1977) 1374-1376
46. (Milano). Pametti L., Mecocci P., Neri C., Palazzetti D., Fiacconi M., Santucci A., et al. Neuroendocrine markers in aging brain: clinical and neurobiological significance of dexamethasone suppression test. Aging 2 (1990) 173-179
47. Dam H., Pedersen H.E., Damkjaer M., and Ahlgren P. dexamethasone suppression test in depressive stroke pateints. Acta Neurologica, Scand 841 (1991) 14-17
48. Olsson T., Astrom M., Eriksson S., and Forssell A. Hypercortisolism, revealed by the dexamethasone suppression test in patients with acute ischaemic stroke. Stroke 20 (1989) 1685-1690
49. Gustafson Y., Olsson T., Eriksson S., Asplund K., and Buch F.G. Acute confusional states (delirium) in stroke patients. Cerebrovasc Dis 1 (1991) 257-264
50. Hamey J.H., Fulton C., Ross E.D., and Rush A.J. Dexamethasone suppression test and onset of poststroke depression in patients with ischemic infarction. J Clin Psychiatry 54 (1993) 343-348
51. Wolkowitz O.M., Reus V.I., Weingertner H., Thompson L., Breier A., Doran A., et al. Cognitive effects of corticosteroids. Am J Psychiatry 147 (1990) 1297-1303
52. Mitchell A.J. The contribution of hypercortisolaemia to the cognitive decline of geriatric depression. Int J Geriatr Psychiatry 10 (1995) 401-410
53. Loosen P.T. Cushing's syndrome and depression. Endocrinologist 4 (1994) 373-382
54. Naber D., Sand P., and Heigl B. Psychopathological and neuroposychological effects of 8-days' corticosteroid treatment. A prospective study. Psychoneuroendocrinol 211 (1996) 25-31
55. Vamey N.R., Alexander B., and MacIndoe J.H. Reversible steroid dementia in patients without steroid psychosis. Am J Psychiatry 141 (1984) 369-372
56. O'Brien J.T. The 'glucocorticoid cascade' hypothesis in man. Prolonged stress may cause permanent brain damage. Br J Psychiatry 170 (1997) 199-201
57. Wade DT, Parker V, Langton-Hewer R, Memory disturbances after stroke Int Rehabil Med 1: 60-64
58. Garcia-Albea E. Confusional state and cerebral infarcts. Postgrad Med J 65 (1989) 286-290 1986
59. Ebrahim S., Nouri F., and Barer D. Cognitive impairment after stroke. Age Ageing 14 (1985) 345-348
60. Mori E., and Yamadori A. Acute confusional state and acute agitated delirium. Occurrence after infarction in the right middle cerebral artery territory. Arch Neurol 4411 (1987) 1139-1149
61. Sharpe M., Hawton K., Seagroatt V., Bamford J., House A., Molyneux A., et al. Depressive disorders in long-term survivors of stroke associations with demographic, and social factors, functional status and brain lesion volume. Br J Psychiatry 164 (1994) 380-386
62. Tatemichi T.K., Paik M., Bagiella E., Desmond D.W., Pirro M., and Hanzawa L.K. Dementia after stroke is a predictor of long-term survival. Stroke 25 (1994) 1915-1919
63. Kitagawa Y., Meyer J.S., Tachibena H., Mortel K.F., and Rogers R.L. CT-CBF correlations of cognitive deficits in multi-infarct dementia. Stroke 15 (1984) 1000-1006
64. Robinson R.G., Bolla-Wilson K., Kaplan E., Lipsey J.R., and Price T.R. Depression influences intellectual impairment in stroke patients. Br J Psychiatry 148 (1986) 541-547
65. House A., Dennis M., Warlow C., Hawton K., and Molyneux A. The relationship between intellectual impairment and mood disorder in the first, year after stroke. Psychol Med 20 (1990) 805-814
66. Robinson R.G., Boston J.A., Starkstein S.E., and Price T.R. Comparison of mania and depression after brain injury: causal factors. Am J Psychiatry 145 (1988) 172-178
67. Andersen G., Vestergaard K., Ingemann-Nielsen M., and Lauritzen L. Risk factors for post-stroke depression. Acta Psychiatr Scand 92 (1995) 193-198
68. Downhill J.E., and Robinson R.G. Longitudinal assessment of depression and cognitive impairment following stroke. J Nerv Ment Dis 182 (1994) 425-431
69. Folstein M.F., Folstein S.E., and McHugh P.R. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12 (1975) 189-198
70. Bolla-Wilson K., Robinson R.G., Starkenstein S.E., and Price T.R. Lateralisation of dementia of depression in stroke patients. Am J Psychiatry 146 (1989) 627-634
71. Agarwal A., Nag D., Kar A.M., Agarwal A.K., and Chowdhury S.R. Dexamethasone suppression test & post stroke depression. Indian J Med Res 85 (1987) 297-301
72. McIntosh T.K., Bush H.L., Yeston N.S., Grasberger R., Palter M., Aun F., et al. Beta-endorphin, cortisol and postoperative delirum: a preliminary report. Psychoneuroendocrinology 10 (1985) 303-313
73. Arana G.W., Baldessarini R.J., and Ornsteen M. The dexamethasone suppression test for diagnosis and prognosis in psychiatry Commentary and review. Arch Gen Psychiatry 42 (1985) 1143-1204
74. Ribeiro S.C.M., Tandon R., Grunhaus L., and Greden J.F. The DST as a predictor of outcome in depression: a meta-analysis. Am J Psychiatry 150 (1993) 1618-1629
75. Barden N., Reul J.M.H.M., and Holsboer F. Do antidepressants stabilize mood through actions on the hypothalamic-pituitary adrenocortical system?. TINS 181 (1995) 6-11
76. Dinan T.G. Glucocorticoids and the genesis of depressive illness A psychobiological model. Br J Psychiatry 164 (1994) 365-371
77. Wolkowitz O.M., Reus V.I., Manfredi F., Ingbar J., and Brizendine L. Antiglucocorticoid strategies in hypercortisolaemic states. Psychopharm Bull 28 (1992) 247-251
78. Starkenstein S.E., and Robinson R.G. Affective disorders and cerebral vascular disease. Br J Psychiatry 154 (1989) 170-182
79. Astrom M., Adolfsson R., and Asplund K. Major depression in stroke patients: a three year longitudinal study. Stroke 24 (1993) 976-982
80. House A. Mood disorders after stroke: a review of evidence. Int J Geriatr Psychiatry 2 (1987) 211-221
81. Burvill P.W., Johnson G.A., Jamrozik K.D., Anderson C.S., Stewart-Wynne E.G., and Chakera T.M.H. Prevalence of depression after stroke: the Perth community stroke study. Br J Psychiatry 166 (1995) 320-327
82. Morris P.L.P., Shields R.B., and Hopwood M.J. Are there two depressive syndromes after stroke?. J Nerv Ment Dis 182 (1994) 230-234
83. Yamaguchi S., Kobayashi S., Koide H., and Tsunematsu T. Longitudinal study of regional cerebral blood flow changes in depression after stroke. Stroke 23 (1992) 1716-1722
84. Grasso M.G., Pantanno P., Ricci M., Intiso D.F., Pace A., Padovani A., et al. Mesial temporal lobe cortex hypoperfusion is associated with depression in subcortical stroke. Stroke 25 (1994) 980-995
85. Harvey SA, Black KJ, The dexamethasone suppression test for diagnosing depression in stroke patients Ann Clin Psychiatry 8: 25-39
86. Ross E.D., and Rush A.J. Diagnosis and neuroanatomical correlates of depression in brain damaged patients: implications for a neurology of depression. Arch Gen Psychiatry 38 (1981) 1344-1354
87. Finkelstein S., Benowitz L.I., Baldessarini R.J., Arana G.W., Levine D., Woo E., et al. Mood vegetative disturbance, and dexamethasone suppression test after stroke. Ann Neurol 12 (1982) 463-468
88. Hamilton M.A. A rating scale for depression. J Neurol Neurosurg Psychiatry 23 (1960) 56-62
89. Zung W.W.K. A self-rating depression scale. Arch Gen Psychiatry 12 (1965) 63-70
90. Wing J.K., Cooper J.E., and Sartorius N. Measurement and classification of psychiatric symptoms (1974), Cambridge University Press, London
91. Harney J.H., Fulton C., Ross E.D., and Rush A.J. Dexamethasone suppression test and onset of poststroke depression in patients with ischemic infarction. J Clin Psychiatry 54 (1993) 343-348
92. Grober S.E., Gordon W.A., Sliwinski M.J., Hibbard M.R., Aletta E.G., and Paddison P.L. Utility of the dexamethasone suppression test in the diagnosis of poststroke depression. Arch Phys Med Rehabil 72 (1991) 1076-1079
93. Malec J.F., Jarrett W., Richardson M.D., Sinaki M., and O'Brien M.W. Types of affective response to stroke. Arch Phys Med Rehabil 71 (1990) 279-284
94. Bauer M., Gans J.S., Harley J.P., and Cobb W. Dexamethasone suppression test and depression in a rehabilitation setting. Arch Phys Med Rehabil 64 (1983) 421-422
95. Udelsman R., Ramp J., Gallucci W.T., Gordon A., Lipford E., Norton J.A., et al. Adaptation during surgical stress, A reevaluation of the role of glucocorticoids. J Clin Invest 77 (1986) 1377-1381
96. McEwen B.S., Angulo J., and Cameron H. Paradoxical effects of adrenal steroids on the brain: protection versus degeneration. Biol Psychiatry 31 (1992) 177-199
97. Jurney T.H., Cockrell J.L., Linberg J.S., Lamiell J.M., and Wade C.E. Spectrum of serum cortisol response to ACTH in ICU patients: correlation with degree of illness and mortality. Chest 92 (1987) 292-295
98. Wade C.E., Lindberg J.S., Cockrell J.L., Lamiell J.M., Hunt M.M., Ducey J., et al. Upon-admission adrenal steroidogenesis is adapted to the degree of illness in intensive care unit patients. J Clin Endocrinol Metabol 67 (1988) 223-227
99. Barthel D., and Mahoney F. Functional evaluation: The Barthel Index. Md State Med J 2 (1965) 61-65
100. Hume R., Vallance B.D., and Muir M.M. Ascorbate status and fibrinogen concentrations after cerebrovascular accident. J Clin Pathol 35 (1982) 195-199
101. (letter). Mulley G.P., Wilcox R.G., and Harison M.J.G. Plasma cortisol as a measure of stress response in acute stroke. Stroke 20 (1989) 1593
102. O'Neill P.A., Davies I., Fullerton K.J., and Bennett D. Stress hormone and blood glucose response following acute stroke in the elderly. Stroke 22 (1991) 842-847
103. Korsic M., Brinar V., Plavsic V., Mihajlovic D., and Giljevic Z. Some aspects of adrenocortical stress response following stroke. Acta Med Iugosl 44 (1990) 137-145
104. Wass C.T., and Lanier W.L. Glucose modulation of ischemic brain injury: review and clinical recommendations. Mayo Clin Proc 71 (1996) 801-812
105. Oppenheimer S.M., Hoffbrand B.I., Oswald G.A., and Yudkin J.S. Diabetes mellitus and early mortality from stroke. BMJ 291 (1985) 1014-1015
106. Morris P.L.P., Robinson R.G., Andrzejewski P., Samuels J., and Price T.R. Association of depression with 10-year poststroke mortality. Am J Psychiatry 150 (1993) 124-129
107. Cruse J.M., Lewis R.E., Bishop G.R., Kliesch W.F., Gaitan E., and Britt R. Decreased immune reactivity and neuroendocrine alterations related to chronic stress in spinal cord injury and stroke patients. Pathobiology 61 (1993) 183-192
108. Wick G., Hu Y., Schwarz S., and Kroemer G. Immunoendocrine communication via the hypothalamo-pituitary-adrenal axis in autoimmune diseases. Endocrinol Rev 14 (1993) 539-563
109. Strijbos P.J., Relton J.K., and Rothwell N.J. Corticotropin-releasing factor antagonist inhibits neuronal damage induced by focal cerebral ischaemia or activation of NMDA receptors in the rat brain. Brain Res 656 (1994) 405-408
110. Smith-Swintosky V.L., Pettigrew L.C., Sapolsky R.M., Phares C., Craddock S.D., Brooke S.M., et al. Metyrapone, an inhibitor of glucocorticoid production, reduces brain injury induced by focal and global ischemia and seizures. J Cereb Blood Flow Met 16 (1996) 585-598
111. Knezevic S., Labs K.-H., Kittner B., and Rößner M. The treatment of vascular dementia: problems and prospects. In: Prohovnik I., Wade J., Knezevic S., Tatemichi T., and Erkinjuntti T. (Eds). Vascular dementia current concepts (1996), Wiley, New York 301-312
112. Reding M.J., Orto L.A., Winter S.W., Kurtuna C.S.W., Di Ponte P., and McDowell F.H. Antidepressant therapy after stroke: a double-blind trial. Arch Neurol 43 (1986) 763-765
113. Dam M., Tonin P., De Boni A., Pizzolato G., Casson S., Ermani M., et al. Effects of fluoxetine and maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy. Stroke 27 (1996) 1211-1214
114. Kling M.A., Geraciot T.D., Licinio J., Michelson D., Oldfield E.H., and Gold P.W. Effects of electroconvulsive therapy on the CRH-ACTH-Cortisol system in melancholic depression: preliminary findings. Psychopharm Bull 30 (1994) 489-494